SCHEMBL21691623

SCHEMBL21691623

N#Cc1c(-c2ccccc2)cc(-c2cccc3c2sc2ccccc23)cc1-c1cccc2sc3ccccc3c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.44
LIMK1 P53667 2/20 0.34
SQOR Q9Y6N5 2/20 0.34
PARP14 Q460N5 1/20 0.34
TNKS O95271 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
F9 P00740 1/20 0.34
ADORA2A P29274 2/20 0.33
ADORA1 P30542 2/20 0.33
MAPK1 P28482 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PRKDC P78527 2/20 0.33
BRDT Q58F21 1/20 0.33
ATM Q13315 1/20 0.33
GPR3 P46089 1/20 0.33
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
KDM4E B2RXH2 1/20 0.32
HSD17B10 Q99714 1/20 0.32
GRM5 P41594 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21691615 0.95 ALOX5 (0.41) ALOX5LIMK1SQORPARP14TNKS
SCHEMBL21693174 0.92 ALOX5 (0.45) ALOX5LIMK1SQORPARP14TNKS
SCHEMBL21691626 0.92 ALOX5 (0.42) ALOX5LIMK1SQORPARP14TNKS
SCHEMBL21692337 0.92 SQOR (0.38) LIMK1SQORF9ADORA2AADORA1
SCHEMBL21693073 0.92 ALOX5 (0.49) ALOX5LIMK1SQORPARP14TNKS
SCHEMBL21693163 0.91 ALOX5 (0.44) ALOX5PARP14ADORA2AADORA1MAPK1
SCHEMBL21693165 0.90 ALOX5 (0.43) ALOX5PARP14TNKSTNKS2PRKDC
SCHEMBL21693176 0.90 ALOX5 (0.41) ALOX5LIMK1SQORPARP14TNKS
SCHEMBL21692614 0.89 ALOX5 (0.43) ALOX5PARP14PRKDCBRDTGPR3
SCHEMBL21693166 0.87 ALOX5 (0.41) ALOX5PARP14TNKSTNKS2PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-07-06 US disclosed
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG SDI CO., LTD. (KR) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound CCNL2, ARL1, CRY1 ALOX5 2220/4885LIMK1 264/4885SQOR 3254/4885
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CCNL2, ARL1, CRY1 ALOX5 2220/4885LIMK1 264/4885SQOR 3254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.